Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
Eukaryotic Cell
|
June 10, 2008
Generating and testing molecular hypotheses in the dermatophytes
Theodore C White, Brian G Oliver, Yvonne Gräser, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 2015
Azole drug import into the pathogenic fungus Aspergillus fumigatus
Brooke D Esquivel, Adam R Smith, Martin Zavrel, et al.
Antimicrobial Agents and Chemotherapy
|
November 17, 2010
An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans
Samantha J Hoot, Adam R Smith, Ryan P Brown, et al.
Eukaryotic Cell
|
July 27, 2010
The UPC2 promoter in Candida albicans contains two cis-acting elements that bind directly to Upc2p, resulting in transcriptional autoregulation
Samantha J Hoot, Ryan P Brown, Brian G Oliver, et al.
Diagnostic Microbiology and Infectious Disease
|
March 16, 2005
Studies of the paradoxical effect of caspofungin at high drug concentrations
David A Stevens, Theodore C White, David S Perlin, et al.
Microbiology (Reading, England)
|
April 5, 2002
Homozygosity at the Candida albicans MTL locus associated with azole resistance
Tige R Rustad, David A Stevens, Michael A Pfaller, et al.
Eukaryotic Cell
|
October 24, 2007
cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p
Brian G Oliver, Jia L Song, Jake H Choiniere, et al.
Medical Mycology
|
October 31, 2006
The Candida albicans mating type like locus [MTL] is not involved in chlamydospore formation
Tige R Rustad, Jake H Choiniere, Dexter H Howard, et al.
Fungal Genetics and Biology : FG & B
|
December 15, 2010
Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model
Rebecca R Achterman, Adam R Smith, Brian G Oliver, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Resistance mechanisms in clinical isolates of Candida albicans
Theodore C White, Scott Holleman, Francis Dy, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
Eukaryotic Cell
|
June 10, 2008
Generating and testing molecular hypotheses in the dermatophytes
Theodore C White, Brian G Oliver, Yvonne Gräser, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 2015
Azole drug import into the pathogenic fungus Aspergillus fumigatus
Brooke D Esquivel, Adam R Smith, Martin Zavrel, et al.
Antimicrobial Agents and Chemotherapy
|
November 17, 2010
An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans
Samantha J Hoot, Adam R Smith, Ryan P Brown, et al.
Eukaryotic Cell
|
July 27, 2010
The UPC2 promoter in Candida albicans contains two cis-acting elements that bind directly to Upc2p, resulting in transcriptional autoregulation
Samantha J Hoot, Ryan P Brown, Brian G Oliver, et al.
Diagnostic Microbiology and Infectious Disease
|
March 16, 2005
Studies of the paradoxical effect of caspofungin at high drug concentrations
David A Stevens, Theodore C White, David S Perlin, et al.
Microbiology (Reading, England)
|
April 5, 2002
Homozygosity at the Candida albicans MTL locus associated with azole resistance
Tige R Rustad, David A Stevens, Michael A Pfaller, et al.
Eukaryotic Cell
|
October 24, 2007
cis-Acting elements within the Candida albicans ERG11 promoter mediate the azole response through transcription factor Upc2p
Brian G Oliver, Jia L Song, Jake H Choiniere, et al.
Medical Mycology
|
October 31, 2006
The Candida albicans mating type like locus [MTL] is not involved in chlamydospore formation
Tige R Rustad, Jake H Choiniere, Dexter H Howard, et al.
Fungal Genetics and Biology : FG & B
|
December 15, 2010
Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model
Rebecca R Achterman, Adam R Smith, Brian G Oliver, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
Resistance mechanisms in clinical isolates of Candida albicans
Theodore C White, Scott Holleman, Francis Dy, et al.
Page
of 7